Alzheimer's Disease (AD)

Neurology·MeSH: Alzheimer Disease

4 drugs in development·3 companies·1 clinical trial

Drug Pipeline by Phase

Approved(1)

Drug	Company
vizamyl	GE HealthCare Technologies Inc. (GEHC)

Phase 2(1)

Drug	Company
NurOwn®	BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Phase 1(1)

Drug	Company
vg-3927	Vigil Neuroscience, Inc. (VIGL)

Preclinical(1)

Drug	Company
nurown	BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

BioSniper tracks 4 drugs in development for Alzheimer's Disease (AD) across 3 companies.

There are 1 clinical trial targeting Alzheimer's Disease (AD) tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.